DNA Methyltransferase 1 Targeting Using Guadecitabine Inhibits Prostate Cancer Growth by an Apoptosis-Independent Pathway
Dev Karan(University of South Carolina), Yogen Saunthararajah(Cleveland Clinic)
Cited by 9
Related Papers
Leukemogenic nucleophosmin mutation disrupts the transcription factor hub that regulates granulomonocytic fates
|Journal of Clinical Investigation|2018|117
Effects of tetrahydrouridine on pharmacokinetics and pharmacodynamics of oral decitabine
|Blood|2011|100
Expression analysis of inflammasome sensors and implication of NLRP12 inflammasome in prostate cancer
|Scientific Reports|2017|62
GATA4 loss of function in liver cancer impedes precursor to hepatocyte transition
|Journal of Clinical Investigation|2017|49
Noncytotoxic Differentiation Treatment of Renal Cell Cancer
|Cancer Research|2011|33